Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4230 | 1747 | 35.8 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
364 | 16680 | FERTILITY AND STERILITY//IVF//OVARIAN HYPERSTIMULATION SYNDROME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | OVARIAN RESERVE | Author keyword | 299 | 55% | 22% | 376 |
2 | ANTI MULLERIAN HORMONE | Author keyword | 218 | 52% | 17% | 294 |
3 | ANTRAL FOLLICLE COUNT | Author keyword | 157 | 71% | 7% | 128 |
4 | AMH | Author keyword | 84 | 45% | 8% | 139 |
5 | OVARIAN RESPONSE | Author keyword | 46 | 43% | 5% | 81 |
6 | ANTIMULLERIAN HORMONE | Author keyword | 44 | 54% | 3% | 57 |
7 | OVARIAN AGING | Author keyword | 33 | 56% | 2% | 40 |
8 | OVARIAN VOLUME | Author keyword | 33 | 50% | 3% | 47 |
9 | CLOMIPHENE CITRATE CHALLENGE TEST | Author keyword | 32 | 88% | 1% | 15 |
10 | BASAL FSH | Author keyword | 25 | 77% | 1% | 17 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OVARIAN RESERVE | 299 | 55% | 22% | 376 | Search OVARIAN+RESERVE | Search OVARIAN+RESERVE |
2 | ANTI MULLERIAN HORMONE | 218 | 52% | 17% | 294 | Search ANTI+MULLERIAN+HORMONE | Search ANTI+MULLERIAN+HORMONE |
3 | ANTRAL FOLLICLE COUNT | 157 | 71% | 7% | 128 | Search ANTRAL+FOLLICLE+COUNT | Search ANTRAL+FOLLICLE+COUNT |
4 | AMH | 84 | 45% | 8% | 139 | Search AMH | Search AMH |
5 | OVARIAN RESPONSE | 46 | 43% | 5% | 81 | Search OVARIAN+RESPONSE | Search OVARIAN+RESPONSE |
6 | ANTIMULLERIAN HORMONE | 44 | 54% | 3% | 57 | Search ANTIMULLERIAN+HORMONE | Search ANTIMULLERIAN+HORMONE |
7 | OVARIAN AGING | 33 | 56% | 2% | 40 | Search OVARIAN+AGING | Search OVARIAN+AGING |
8 | OVARIAN VOLUME | 33 | 50% | 3% | 47 | Search OVARIAN+VOLUME | Search OVARIAN+VOLUME |
9 | CLOMIPHENE CITRATE CHALLENGE TEST | 32 | 88% | 1% | 15 | Search CLOMIPHENE+CITRATE+CHALLENGE+TEST | Search CLOMIPHENE+CITRATE+CHALLENGE+TEST |
10 | BASAL FSH | 25 | 77% | 1% | 17 | Search BASAL+FSH | Search BASAL+FSH |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTIMULLERIAN HORMONE | 221 | 67% | 11% | 200 |
2 | INHIBITING SUBSTANCE LEVELS | 125 | 86% | 4% | 63 |
3 | ANTRAL FOLLICLE COUNT | 125 | 67% | 6% | 113 |
4 | ANTI MULLERIAN HORMONE | 114 | 27% | 21% | 366 |
5 | CITRATE CHALLENGE TEST | 110 | 79% | 4% | 71 |
6 | INHIBITING SUBSTANCE | 87 | 42% | 9% | 160 |
7 | AMH | 83 | 69% | 4% | 70 |
8 | OVARIAN RESERVE | 70 | 45% | 7% | 118 |
9 | DAY 3 ESTRADIOL | 69 | 73% | 3% | 53 |
10 | BECKMAN COULTER ELISA | 61 | 95% | 1% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Ovarian response biomarkers: physiology and performance | 2015 | 2 | 35 | 91% |
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice | 2014 | 28 | 131 | 76% |
Antimullerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis | 2015 | 2 | 63 | 84% |
The physiology and clinical utility of anti-Mllerian hormone in women | 2014 | 27 | 164 | 66% |
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) | 2010 | 216 | 143 | 69% |
The Measurement of Anti-Mullerian Hormone: A Critical Appraisal | 2014 | 11 | 38 | 87% |
A systematic review of tests predicting ovarian reserve and IVF outcome | 2006 | 402 | 124 | 73% |
What is the "ovarian reserve''? | 2015 | 1 | 4 | 75% |
Anti-Mullerian hormone (AMH): what do we still need to know? | 2009 | 112 | 91 | 78% |
Can Anti-Mullerian Hormone Predict the Diagnosis of Polycystic Ovary Syndrome? A Systematic Review and Meta-Analysis of Extracted Data | 2013 | 30 | 57 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | OBSTET NEONATOL GYNECOL | 10 | 50% | 0.9% | 15 |
2 | ASSISTED REPROD EMBRYOL | 9 | 83% | 0.3% | 5 |
3 | MOTHER INFANT | 5 | 17% | 1.7% | 29 |
4 | ENDOCRINE GYNAECOL REPROD MED | 5 | 38% | 0.6% | 11 |
5 | REPROD MED GYNAECOL | 5 | 19% | 1.3% | 23 |
6 | REPROD MED GYNECOL | 3 | 16% | 1.1% | 20 |
7 | FEMALE BABY | 3 | 100% | 0.2% | 3 |
8 | ZAKLAD STAT INFORMAT MED | 3 | 100% | 0.2% | 3 |
9 | NATALITA | 3 | 45% | 0.3% | 5 |
10 | KLIN ROZRODCZOSCI ENDOKRYNOL GINEKOL | 3 | 50% | 0.2% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000203346 | AGE AT MENOPAUSE//AGE AT NATURAL MENOPAUSE//EARLY MENOPAUSE |
2 | 0.0000187595 | RECOMBINANT FSH//GNRH ANTAGONIST//OVARIAN STIMULATION |
3 | 0.0000173351 | PERSISTENT MULLERIAN DUCT SYNDROME//TRANSVERSE TESTICULAR ECTOPIA//UNITE RECH ENDOCRINOL DEV |
4 | 0.0000095606 | ENDOMETRIAL THICKNESS//THIN ENDOMETRIUM//FOLLICULAR VASCULARITY |
5 | 0.0000094326 | PREMATURE OVARIAN FAILURE//PRIMARY OVARIAN INSUFFICIENCY//AUTOIMMUNE OOPHORITIS |
6 | 0.0000088770 | SINGLE OVARY//CONTRALATERAL OVULATION//IPSILATERAL OVULATION |
7 | 0.0000084978 | BMP15//GDF9//BONE MORPHOGENETIC PROTEIN 15 |
8 | 0.0000078947 | INTRAUTERINE INSEMINATION//FALLOPIAN TUBE SPERM PERFUSION//UNEXPLAINED INFERTILITY |
9 | 0.0000071228 | ADVANCED MATERNAL AGE//DELAYED CHILDBEARING//GRAND MULTIPARA |
10 | 0.0000069159 | LUTEAL PHASE SUPPORT//LUTEAL SUPPORT//VAGINAL PROGESTERONE |